Applications
Online Inquiry
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Non-Human Primate (NHP) Applications in Biologics & Complex Modalities
Accelerate Your Biologics Development! Are you currently facing challenges with long drug development cycles, immunogenicity testing, or obtaining high-quality preclinical data for complex modalities? Our NHP based services help you accelerate drug discovery and streamline clinical trial processes by leveraging advanced recombinant DNA technology and comprehensive bioanalytical platforms.
Leveraging NHP Models in Biologics and Complex Modalities to Accelerate Your Drug Discovery Pathway!
NHP models provide essential translational data for AAV vector safety and biodistribution, helping to bridge preclinical research and human clinical trials.
Overview of NHP Applications
What Are Our Research Areas?
NHPs are critical for the preclinical evaluation of biologics and complex modalities, acting as a bridge between foundational research and human clinical trials. These studies are essential for understanding how novel therapeutics behave in a system that closely mirrors human physiology.
- Receptor Occupancy & Target Engagement: To confirm that a drug binds to its intended target at the required dose.
- PK/PD Bridging for ADCs & Bispecifics: To understand the relationship between drug concentration and its pharmacological effect.
- Immunogenicity & Off-Target Safety: To evaluate the potential for unwanted immune responses and unintended side effects.
Why Choose Us?
The use of non-human primates in preclinical research is often necessary due to their high degree of physiological and genetic similarity to humans. This makes them the gold standard for predicting human responses, particularly for novel biologics that may not be pharmacologically active in other species. Key advantages include:
- Genetic/immunological similarities: NHPs share a high degree of genetic homology with humans, leading to more relevant immune responses.
- Clinical translational relevance: Data from NHP models are highly predictive of human outcomes, reducing the risk of clinical trial failure.
- Data types required for regulatory submissions: Regulatory bodies often require NHP data for Investigational New Drug (IND) applications, especially for gene and cell therapies.
Distributed under Unsplash License, from Unsplash.
Key Applications
Our NHP models are a powerful tool for a wide range of therapeutic applications, providing crucial data that cannot be obtained from other animal species.
- Vector Biodistribution and Shedding Studies for Gene Therapies: NHPs are used to track the distribution of gene therapy vectors (e.g., AAVs) throughout the body and monitor for vector shedding in various tissues and fluids. This is a key requirement for regulatory submissions to assess safety.
- Modeling Cytokine Release Syndrome (CRS) for CAR-T Therapies: The immune systems of NHPs are similar enough to humans to allow for the assessment of potential on-target and off-tumor toxicity, including the dangerous cytokine storm associated with CAR-T cell therapies.
- Receptor Occupancy Studies for Bi-specifics and ADCs: Due to target specificity, NHPs are often the only relevant species for assessing the binding of novel bi-specifics and antibody-drug conjugates to their intended targets in vivo.
- Tumor Microenvironment Studies for Immuno-oncology: NHPs can be used to model the complex tumor microenvironment, providing a more accurate assessment of the efficacy of immunotherapies like checkpoint inhibitors.
How Do Creative Biolabs Support Your Projects?
At Creative Biolabs, we provide a comprehensive suite of services to support your NHP studies. We offer integrated solutions from sample collection to advanced bioanalysis to ensure you get the high-quality, actionable data you need. For more details on these services and how they can be tailored to your project, we encourage you to Contact Our Team for More Information.
| Service Capability | Corresponding Application Area |
| DMPK & PK/PD Evaluation | This service is crucial for understanding drug concentration and pharmacological effects, especially for complex modalities like ADCs. |
| Safety & Toxicology | Our services in this area are vital for assessing vector safety, off-target effects, and potential toxicities like cytokine release syndrome. |
| Advanced Therapy Efficacy Studies | We help evaluate therapeutic efficacy and the drug's mechanism of action in relevant disease models. |
| Receptor Occupancy (Flow Cytometry) | This provides critical data for receptor occupancy studies, and identifying key biomarkers. |
Translational Impact
Leveraging NHP models is a strategic move that significantly enhances your chances of success in the clinic. The data generated provides a more reliable early proof of concept and enables early detection of immune responses or toxicity. NHP biodistribution and safety data are often required for gene therapy IND submissions, directly reducing the risk of IND failure. This proactive approach helps to ensure a smoother, faster path to clinical trials and ultimately, to patients.
Frequently Asked Questions
Q: How do you ensure the quality and reproducibility of the data from NHP studies?
A: We follow stringent quality control protocols and are committed to generating high-quality, reproducible data. Our experienced scientists, state-of-the-art facilities, and validated assays ensure the reliability of all results. For a detailed discussion on our quality assurance practices, please contact us.
Q: What types of samples can you handle from NHP studies?
A: Our capabilities include a wide range of bio-specimens. We handle everything from blood, serum, and plasma to PBMCs, immune cells, CSF, and various tissue panels. We also provide custom collection services tailored to your study design.
Q: How do NHP studies compare to rodent models for biologics?
A: While rodent models are useful for initial screening, NHPs are often the only relevant species for biologics and complex modalities due to their genetic and physiological similarity to humans. This allows for more accurate predictions of PK/PD profiles, immunogenicity, and safety, which is crucial for de-risking a program before it enters clinical trials.
Q: What is the process for setting up a new NHP study with your team?
A: The process begins with a consultation where we discuss your specific research goals, therapeutic modality, and regulatory requirements. Our team then designs a customized study protocol that aligns with your objectives and budget. We provide comprehensive support throughout the study, from protocol design to final data reporting.
Contact Us
Creative Biolabs offers a comprehensive and robust platform for NHP applications, providing crucial data for the development of biologics and complex modalities. Our expertise ensures high-quality, translationally relevant data that de-risks your program and accelerates your path to the clinic. Are you prepared to utilize our NHP platform for your upcoming research? Reach out to our team for further details and to explore your project.